Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1993
05/27/1993CA2124086A1 Tocotrienols and tocotrienol-like compounds and methods for their use
05/27/1993CA2124003A1 Phenol derivatives as agonists of a cyclic amp dependent protein kinase
05/27/1993CA2124002A1 3-pyridinol derivatives and their use as medicaments
05/27/1993CA2124001A1 2-pyridinol derivatives and their use as medicaments
05/27/1993CA2123418A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
05/27/1993CA2120134A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation
05/27/1993CA2117285A1 Use of interleukin-8
05/27/1993CA2117282A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them
05/27/1993CA2100466A1 Unbuffered premixed ranitidine formulation
05/27/1993CA2083622A1 Certain macrocyclic lactam derivatives
05/26/1993EP0543584A1 Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system
05/26/1993EP0543491A2 Angiotensin II antagonists having a substituted 1,3-benzodioxolering or 1,3-benzodithiolering
05/26/1993EP0543476A1 Use of interleukin-8
05/26/1993EP0543417A1 Tocotrienols and tocotrienol-like compounds and methods for their use
05/26/1993EP0543310A2 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same
05/26/1993EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY
05/26/1993EP0542912A1 Calcium and trace mineral supplements.
05/26/1993EP0542880A1 Tissue bonding and sealing composition and method of using the same
05/26/1993EP0542807A1 Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one
05/26/1993CN1020924C Production of pluripotent granule cell colony stimulating factor
05/26/1993CN1020903C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives and the preparation therefor
05/25/1993US5214206 Anticholesterol agents, inhibitors of acylcoenzyme A
05/25/1993US5214204 Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity
05/25/1993US5214191 Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
05/25/1993US5214067 Fungicidal compositions and method
05/25/1993US5214060 Pyridylalkylpiperidine or pyrolidine
05/25/1993US5214040 Side effect reduction
05/25/1993US5214030 Urogenital disorders
05/25/1993CA1318461C Tripeptide derivatives
05/25/1993CA1318253C Stabilized pergolide compositions
05/19/1993EP0542679A1 Novel hybrid transforming growth factors
05/19/1993EP0542630A2 Use of derivatives of amphotericin B as protease inhibitors
05/19/1993EP0542554A1 Substituted N-biphenylyl lactams
05/19/1993EP0542398A1 Rice extract useful as active oxygen scavenger
05/19/1993EP0542372A1 2-Substituted saccharin derivative proteolytic enzyme inhibitors
05/19/1993EP0542371A1 Saccharin derivative proteolytic enzyme inhibitors
05/19/1993EP0542364A1 Controlled release device
05/19/1993EP0542355A1 Amorphous (Quinolin-2-ylmethoxy)indoles as leukotriene antagonists
05/19/1993EP0541716A1 Novel methods and compositions for treatment of angiogenic diseases
05/19/1993EP0541705A1 Substituted 1h-imidazol-5-yl]alkanoic acids
05/19/1993EP0541654A1 Bombesin antagonists
05/19/1993EP0541594A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use.
05/19/1993EP0541593A1 Cyclopentane derivatives, process for producing them and their pharmaceutical use.
05/19/1993EP0408713B1 Phenylsulphone derivatives
05/19/1993DE4137333A1 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung Therapeutic agents which are antagonists or partial agonists of human interleukin 4 are or contain hIL-4 mutant proteins as well as for their preparation vefahren
05/19/1993CA2082839A1 Pharmaceutical compounds
05/18/1993US5212201 Xanthine oxidase inhibitor
05/18/1993US5212187 Pyridyl alkylamine compounds which are useful against histamine h1 and h2 receptors
05/18/1993US5212185 Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/18/1993US5212178 Compounds for treatment of Parkinson*s Disease
05/18/1993US5212166 Antiandrogens or 5-alpha reductase inhibitors
05/18/1993US5212165 Enzyme inhibitor
05/18/1993US5212160 Autoimmune disease, aging or bronchopulmonary disease
05/18/1993US5212157 Tetrapeptides as inhibitors of HIV
05/18/1993US5211950 Stabilized calcitonin pharmaceutical composition
05/18/1993US5211945 Compositions and methods for modulating the effect of tnf and il-1
05/18/1993US5211938 Method of detection of malignant and non-malignant lesions by photochemotherapy of protoporphyrin IX percursors
05/18/1993CA1317960C Derivatives of bicyclic aminocarboxylic acids, a process and intermediates for their preparation, and their use
05/18/1993CA1317959C 5-(_-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes
05/18/1993CA1317942C 5-hetero-or aryl-substituted-imidazol¬2,1-a| isoquinolines
05/16/1993CA2082774A1 Saccharin derivative proteolytic enzyme inhibitors
05/16/1993CA2079822A1 2-substituted saccharin derivative proteolytic enzyme inhibitors
05/15/1993WO1993009791A2 Use of amphotericin b derivatives as protease inhibitors
05/15/1993CA2099490A1 Use of amphotericin b derivatives as protease inhibitors
05/14/1993CA2082787A1 Substituted n-biphenylyl lactams
05/13/1993WO1993009236A1 Myogenic vector systems
05/13/1993WO1993009229A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
05/13/1993WO1993009228A1 TGF-β TYPE RECEPTOR cDNAS AND USES THEREFOR
05/13/1993WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination
05/13/1993WO1993009136A1 Phosphonopeptides with collagenase inhibiting activity
05/13/1993WO1993009135A1 Peptides inhibiting il-1 beta release
05/13/1993WO1993009104A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists
05/13/1993WO1993009097A1 Collagenase inhibitor
05/13/1993WO1993009096A1 Hiv protease inhibitors useful for the treatment of aids
05/13/1993WO1993009090A1 Hydroxamic acid derivative
05/13/1993WO1993008821A1 Side effect inhibitor for cancer therapy
05/13/1993WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/13/1993WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof
05/13/1993WO1993008799A1 Endothelin receptor antagonists
05/13/1993WO1993008790A1 Treatment of acne or of pseudofolliculitis barbae
05/13/1993WO1993008687A1 Alteration of rate and character of hair growth
05/13/1993WO1993005751A3 Osteogenic proteins in the treatment of bone deseases
05/13/1993CA2123104A1 Collagenase inhibitor
05/13/1993CA2122991A1 Transfection of vertebrate cells by homologous recombination
05/13/1993CA2122820A1 Endothelin receptor antagonists
05/13/1993CA2122617A1 Myogenic vector systems
05/13/1993CA2122491A1 Tgf-.beta. type receptor cdnas and uses therefor
05/13/1993CA2122147A1 Phosphonepeptides with collagenase inhibiting activity
05/13/1993CA2122046A1 Hydroxamic acid derivative
05/13/1993CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof
05/13/1993CA2118688A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
05/13/1993CA2116653A1 Peptides inhibiting il-1 beta release
05/12/1993EP0541486A1 Polycyclic conjugates
05/12/1993EP0541407A1 Nitrogen containing bicyclic derivatives, method for their preparation and pharmaceutical compositions containing them
05/12/1993EP0541168A1 HIV protease inhibitors useful for the treatment of aids
05/12/1993EP0540914A1 2-Aminomethylchromans as active ingredients in medicaments for the treatment of diseases of the central nervous system
05/12/1993EP0540859A1 Anthracycline prodrugs
05/12/1993EP0540767A1 Treatment of lyso paf-mediated diseases with paf antagonists and procedure for determining their efficacy
05/12/1993EP0540757A1 Water-based recording ink
05/12/1993EP0540747A1 Medicine for intraocular operation
1 ... 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 ... 1564